Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
Alan Wright, Kyle E Luedtke, Chad VanDenBergCenter for Clinical Research, Mercer University, Atlanta, Georgia, USAAbstract: Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved by the US Food and Drug Administration for the treatment of fibromyalgia and painful diabetic neuropathy at...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-12-01
|
Series: | Journal of Pain Research |
Online Access: | http://www.dovepress.com/duloxetine-in-the-treatment-of-chronic-pain-due-to-fibromyalgia-and-di-a5912 |